GenSight Biologics
SIGHT.PA
#9779
Rank
โ‚ฌ30.18 M
Marketcap
0,24ย โ‚ฌ
Share price
2.17%
Change (1 day)
-41.20%
Change (1 year)

EPS for GenSight Biologics (SIGHT.PA)

EPS in 2023: -0,55ย โ‚ฌ

According to GenSight Biologics's latest financial reports the company's current EPS (TTM) is -0,55ย โ‚ฌ. In 2023 the company made an earnings per share (EPS) of -0,55ย โ‚ฌ an increase over its 2022 EPS that were of -0,59ย โ‚ฌ.

EPS history for GenSight Biologics from 2013 to 2023

Annual EPS

Year EPS Change
2023-0,55ย โ‚ฌ-7.25%
2022-0,59ย โ‚ฌ-10.2%
2021-0,66ย โ‚ฌ-39.55%
2020-1,09ย โ‚ฌ-3.12%
2019-1,13ย โ‚ฌ-22.02%
2018-1,45ย โ‚ฌ18.91%
2017-1,22ย โ‚ฌ-7.74%
2016-1,32ย โ‚ฌ8.29%
2015-1,22ย โ‚ฌ121.37%
2014-0,55ย โ‚ฌ112.76%
2013-0,26ย โ‚ฌ